Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Ingebrigtsen, S. F. Thomsen, K. O. Kyvik, E. K. Silverman, J. Vestbo, V. Backer (Copenhagen, Odense, Denmark; Boston, United States Of America). Genetic influence on chronic mucus hypersecretion – a twin study. Eur Respir J 2008; 32: Suppl. 52, 1162

Member's Comments

No comment yet.

Related content which might interest you: Risk of chronic bronchitis and chronic mucus hypersecretion in twin pairs discordant for smoking Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases Year: 2010 Susceptibility to chronic mucus hypersecretion: A genome-wide association study Source: Annual Congress 2011 - Genes, environment and obstruction Year: 2011 Revisited role for mucus hypersecretion in the pathogenesis of COPD Source: Eur Respir Rev 2009; 19: 109-112 Year: 2010 Chronic mucus hypersecretion in severe asthma Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD Source: Eur Respir J 2015; 45: 60-75 Year: 2015 Prevalence and predictors of chronic mucus hypersecretion in young Danish adults Source: Eur Respir J 2001; 18: Suppl. 33, 275s Year: 2001 A pilot study on the efficacy of erdostein in patients with mucus hypersecretion Source: Annual Congress 2007 - Critical care and airways clearance Year: 2007 Chronic mucus hypersecretion in asthma: Relation to smoking status and disease severity Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 A pilot study of high frequency chest wall oscillation therapy in COPD with mucus hypersecretion Source: Annual Congress 2008 - Technologies and techniques in rehabilitation Year: 2008 Relationships between lung physiology and airway and systemic inflammation: a cohort study in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006 Infectional factors influences on expressiveness of inflammatory process and structural changes in bronchial mucosa at COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 576s Year: 2006 Association of bronchial hyperresponsiveness and airway inflammation in a community based longitudnal cohort Source: Eur Respir J 2006; 28: Suppl. 50, 250s Year: 2006 Evolution of asthma in relation to the bronchial inflammatory phenotype: a follow-up study Source: International Congress 2018 – Asthma analysis Year: 2018 Effect of sildenafil on mucus hypersecretion of rat airway Source: Eur Respir J 2007; 30: Suppl. 51, 523s Year: 2007 The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort Source: Annual Congress 2008 - Outcome and trends in obstructive lung disease (OLD) and cardiovascular relation to OLD Year: 2008 Characterization and effects of bronchial colonization and inflammation in stable COPD patients. PAC-COPD study Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Genetic influence on smoking – a twin study Source: Annual Congress 2007 - The versatile aspects of nicotine addiction Year: 2007 The influence of smoking on the formation of cold airway hyperresponsiveness and destructive-cytolytic profile of goblet cells in asthma patients Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Epigenetics and prenatal influences on asthma and allergic airways disease Source: Breathe 2014; 10: 24-31 Year: 2014 Epigenetics and prenatal influences on asthma and allergic airways disease Source: Annual Congress 2013 –PG6 Epigenetics of asthma and COPD Year: 2013